Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China flag China · Delayed Price · Currency is CNY
27.96
-0.08 (-0.29%)
Apr 29, 2026, 3:00 PM CST

SHA:688566 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
689.16781.32847.48694.87903.91,025
Trading Asset Securities
81.0937.03563590200
Cash & Short-Term Investments
770.25818.36903.48729.87993.91,225
Cash Growth
-16.87%-9.42%23.79%-26.57%-18.87%-4.84%
Accounts Receivable
401.84366.28300.75369.15216.21146.6
Other Receivables
0.441.390.050.030.02-
Receivables
402.28367.66300.8369.17216.23146.6
Inventory
36.7834.0730.729.5132.6631.83
Other Current Assets
47.0734.4769.462.5913.982.62
Total Current Assets
1,2561,2551,3041,1311,2571,406
Property, Plant & Equipment
1,0401,031986.86832.49552.21271.51
Long-Term Investments
84.4785.9479.79126.1961.7456.63
Goodwill
35.3335.33----
Other Intangible Assets
57.5958.0356.6958.259.7461.28
Long-Term Deferred Tax Assets
24.3522.6417.9316.1315.5911.72
Long-Term Deferred Charges
63.2859.7432.141.132.183.25
Other Long-Term Assets
161.71170.1949.6944.3816.348.21
Total Assets
2,7232,7172,5282,2101,9651,819
Accounts Payable
64.3574.2997.1591.22101.6769.92
Accrued Expenses
11.3625.2745.7386.7953.4935.3
Short-Term Debt
1.6816.5220.839.91--
Current Income Taxes Payable
27.7734.072.010.196.095.19
Current Unearned Revenue
5.056.40.951.813.421.51
Other Current Liabilities
24.0920.4718.5320.3916.6912.14
Total Current Liabilities
134.31177.01185.19210.31181.36124.06
Long-Term Debt
-2.2----
Long-Term Unearned Revenue
58.7158.3958.5959.0458.8559.7
Long-Term Deferred Tax Liabilities
3.093.233.253.253.4-
Other Long-Term Liabilities
26.6426.6426.6426.6426.6426.64
Total Liabilities
222.75267.47273.68299.25270.24210.4
Common Stock
199.43199.43199.43189.08186.94186.94
Additional Paid-In Capital
1,3321,3231,2991,0821,0421,021
Retained Earnings
949.67907.68749.77633.4459.17394.24
Comprehensive Income & Other
0.070.01----
Total Common Equity
2,4812,4302,2491,9051,6881,602
Minority Interest
18.619.65.235.585.96.31
Shareholders' Equity
2,5002,4502,2541,9101,6941,608
Total Liabilities & Equity
2,7232,7172,5282,2101,9651,819
Total Debt
1.6818.7220.839.91--
Net Cash (Debt)
768.56799.64882.65719.96993.91,225
Net Cash Growth
-14.87%-9.40%22.60%-27.56%-18.87%-4.84%
Net Cash Per Share
3.844.004.553.845.336.50
Filing Date Shares Outstanding
199.97199.43199.43189.08186.94186.94
Total Common Shares Outstanding
199.97199.43199.43189.08186.94186.94
Working Capital
1,1221,0781,119920.841,0751,282
Book Value Per Share
12.4112.1811.2810.079.038.57
Tangible Book Value
2,3892,3372,1921,8471,6291,541
Tangible Book Value Per Share
11.9411.7210.999.778.718.24
Buildings
--142.66142.66142.52142.52
Machinery
--75.2674.8173.3772.78
Construction In Progress
--917.62754.62466.36175.48
Source: S&P Global Market Intelligence. Standard template. Financial Sources.